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Implications for 
 Nursing Care 
Juvenile Myoclonic Epilepsy 






Symptoms of JME 
A 15 year old white male is 
admitted to the pediatric 
intensive care unit from the 
emergency department, 
accompanied by his mother. The 
juvenile is unable to maintain a 
wakeful state, therefore, initial 
information is obtained from his 
mother.  The mother reports her 
son had stayed  at a friend’s 
house overnight,  she received a 
phone call from the friend’s 
mother this morning stating her 
son had a seizure.  The juvenile 
was brought to the emergency 
room by ambulance.  The mother 
reports the information she 
received was that her son and his 
friend had been up all night 
playing video games.  While 
playing, the juvenile fell from the 
edge of the bed into the floor and 
began convulsing, followed by an 
episode of vomiting.  The episode 
was reported to have lasted 
about two minutes.  The mother 
reports the juvenile has no 
known history of seizures, no 
prior medical conditions.  
Diagnostic evaluation completed 
in the ER includes MRI and 
laboratory testing.  MRI results 
indicate no abnormalities.  
Laboratory testing reveals 
complete blood count, and 
comprehensive metabolic panel 
within normal limits; elevated 
lactate, and creatine kinase; drug 
and alcohol screening are 
negative.  Vital signs are within 
normal limits. The juvenile has 
abrasions to his forehead, and 
bite marks to his tongue.  After 
waking, the juvenile states he 
does not recall the episode.  
However, he reports that 
throughout the night he noticed 
he had been having some jerking 
episodes of both his hands that 
would cause him to drop his 
video game controller, he also 
reports that following this jerking 
episodes he briefly forgot what 
he was doing.  EEG results are 
abnormal, with findings 
consistent with juvenile 
myoclonic epilepsy. 
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Juvenile myoclonic epilepsy 
(JME) is one of the most 
common epilepsies of 
childhood (Korff, Nordli, & 
Eichler, 2014).  JME typically 
occurs in otherwise healthy 
teenagers, and is 
characterized by one or more 
of the following seizure types: 
myoclonic jerks, generalized 
tonic clonic seizures, and 
absence seizures (Korff, 
Nordli, & Eichler, 2014).  JME 
is thought to have genetically 
mediated factors (Park, 
Shahid, & Jammoul, 2015).  
JME is considered to be 
gender equal (Korff, Nordli, & 
Eichler, 2014).  Most JME 
patients are diagnosed 
between 12 and 18 years of 
age (Korff, Nordli, & Eichler, 
2014).  Triggers linked to 
onset of seizure activity 
include: sleep deprivation, 
fatigue, alcohol, mental stress, 
and flashing lights (Park, 
Shahid, & Jammoul, 2015).  
Although the frequency of 
seizures typically decreases as 
the individual progresses 
through adulthood, JME is 
usually a life-long disease 
(Korff, Nordli, & Eichler, 
2014).  The majority of 
patients with JME respond to 
antiepileptic treatment, and 
are able to live free from 
seizure, as long as they 
maintain treatment (Afra & 
Adamolekun, 2011).  
However, antiepileptic 
medication can have adverse 
effects, possibly leading to 
poor tolerance, and 
compliance with treatment 
(Afra & Adamolekun, 2011).  
Education of JME patients and 
their families, by their 
healthcare provider, on 
disease and treatment 
(including non-
pharmacological treatment 
such as life-style modification) 
is essential for disease 
management, and improved 
patient outcomes.  
Juvenile myoclonic epilepsy is 
characterized by myoclonic jerks that 
usually occur after awakening, and 
are described as shock-like or 
arrhythmic movements of both arms 
(Sirven & Fisher, 2013).  Patient’s with 
JME may present with myoclonus, 
generalized tonic-clonic seizure, or 
absence seizure (Korff, Nordli, & 
Eichler, 2014).  However, most 
patient’s present following a 
generalized tonic-clonic seizure, and 
further assessment, and testing leads 
to diagnosis of JME (Korff, Nordli, & 
Eichler, 2014).  Interictal EEG pattern 
in JME is classically, “4 to 6 Hz 
bilateral polyspike and slow wave 
discharges with frontal predominance 
over a normal background activity 
(Korff, Nordli, & Eichler, 2014, p.3).  
However, other abnormalities are less 
commonly noted including, “2.5 to 4.5 
Hz bilateral spike-waves, single 
spikes, and irregular spike-wave 
complexes” (Korff, Nordli, & Eichler, 
2014, p.3).  JME typically manifests 
during adolescence, and persists into 
adulthoold (NIH, 2012).     
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 Although the etiology of JME 
remains unknown, it can be 
successfully diagnosed by thorough 
assessment of patient history, 
presentation, and testing.  With 
appropriate, and consistent 
antiepileptic drug treatment, and 
lifestyle modification, most patients 
are able to remain seizure free.  
Many of the potential seizure 
triggers in JME are particularly 
common for teenagers to 
experience such as lack of sleep, 
stress, and flashing lights.  Juveniles 
newly diagnosed with JME, and their 
families, need to be well educated 
on the disease, disease treatment, 
and safety considerations to 
promote the best outcomes for the 
juvenile.    . 
 
Conclusion 
An epileptic seizure results from 
neurologic dysfunction with abnormal 
neuronal firing, manifesting as changes in 
motor control, abnormal sensory 
perception, abnormal behavior, and/or 
abnormal autonomic function (Stafstrom & 
Rho, 2014).  Epilepsy results from cellular 
level biochemical processes that promote 
aberrant electrical activity causing neuronal 
hyperexcitability, and hypersynchrony 
(Stafstrom & Rho, 2014).  Juvenile myolonic 
epilepsy is an idiopathic generalized 
epilepsy syndrome (Carroll, 2013).  JME 
seizures are linked with cortical 
hypersensitivity (Korff, Nordli, & Eichler, 
2014).  Routine brain analysis of patients 
with JME is typically normal (Carroll, 2013).  
However, advanced imaging techniques 
Underlying Pathophysiology 
have suggested “involvement of frontal 
thalamocortical circuits and dysfunction in 
the dopaminergic and serotoninergic 
neurotransmission systems” (Korff, Nordli, & 
Eichler, 2014, p. 2).  The underlying cause of 
JME remains unknown (Korff, Nordli, & 
Eichler, 2014).  Several research studies have 
shown that genetic factors play a role in JME 
(Mefford et. al., 2010).  At least 15 
chromosomal loci are suspected in playing a 
role in JME including: EFHC1, GABRA1, CLCN2 
(Korff, Nordli, & Eichler, 2014), CPA6 (Sapio, 
et. al., 2015), and BRD2 (Velisek, et. al., 
2011).  Some studies have found a slightly 
higher rate of JME among females, but most 
studies have found JME to be gender equal 
(Korff, Nordli, & Eichler, 2014). 
 
The generalized tonic-clonic seizure (GTCS) 
of JME that often leads to the patient 
seeking medical attention is similar to GTCS 
of other causes (Wilfong, 2014).  Also, 
neuroimaging often fails to find any 
abnormalities in patients with JME (Korff, 
Nordli, & Eichler, 2014). Given the unclear 
etiology of JME, the lack of abnormal 
structural findings, and the number of 
causes that can lead to GTCS, a careful 
history is very important for accurate 
diagnosis of JME (Wilfong, 2014).  The 
clinician should obtain information related 
to: the setting in which the episode 
occurred including time of day, recent 
illness or new medication, behavior 
immediately prior to the event, 
activity engaged in immediately prior to 
event, was the event accompanied by 
other conditions such as headache, were 
any focal symptoms present such as 
twitching, a physical description of the 
event related to body movements and 
duration of event, behavior after the 
event including confusion or focal 
findings (Wilfong, 2014).  A family history 
should also be obtained (Wilfong, 2014).  
Although some patients with JME will 
have normal EEG findings, EEG should be 
performed to help confirm diagnosis of 
JME (Wilfong, 2014).   
 
Significance of Pathophysiology 
 Accurate diagnosis of JME, 
differentiation from other seizure 
disorder, is imperative for accurate 
treatment (Korff, Nordli, & Eichler, 
2014).  Some antiepileptic drugs are 
ineffective, or contraindicated in 
JME (Schachter, 2015).  With 
appropriate antiepileptic drug 
therapy, most patients respond 
quickly, and completely but will still 
require lifelong treatment (Korff, 
Nordli, & Eichler, 2014).  Patients 
should be educated that they need 
to continue drug treatment even 
after prolonged periods of remission 
from seizure (Korff, Nordli, & Eichler, 
2014).  Patients should be educated 
to avoid seizure triggers (Korff, 
Nordli, & Eichler, 2014).  Patients 
should also be educated on lifestyle 
modifications related to potential 
safety concerns surrounding 
swimming/bathing, driving, and 
other potentially dangerous 
activities (Korff, Nordli, & Eichler, 
2014).  Consistent seizure control to 
decrease, or prevent seizure 
episodes is imperative to prevent 
seizure comorbidity, and disability 
(Kessler, Lane, Shahly, & Stang, 
2012).   
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